Company: MIRA
Filing Date: 2025-09-11
Form Type: 8-K
Source: 0001493152-25-013100
Chunk: 3

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-09-11
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item
9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                                   
      No.                                                                                                                                                                                                    
     10.1      MIRA Pharmaceuticals, Inc. 2022 Omnibus Incentive Plan (incorporated herein by reference to Appendix F of the Company’s Definitive Proxy Statement on Schedule 14A filed on August 8, 2025).  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover                                                                                                                                                                                         

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                          MIRA                                         
  Dated:                  By:                       /s/                
                          Name:                     Erez               
                          Title:                    Chief